Sagimet Biosciences (SGMT) Interest Expenses (2022 - 2026)
Sagimet Biosciences (SGMT) posted quarterly Interest Expenses of $2.0 million for Q1 2026, up 7565.38% year-over-year from $26000.0 in Q1 2025, and down 47.54% quarter-over-quarter from $3.8 million in Q4 2025.
Sagimet Biosciences (SGMT) Interest Expenses (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Interest Expenses history runs 5 years deep, the most recent figure standing at $2.0 million for Q1 2026.
- In Q1 2026, Interest Expenses rose 7565.38% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $2.0 million (up 7565.38% YoY), while the FY2025 annual figure was $3.8 million, down 94.28% from the prior year.
- Interest Expenses for Q1 2026 stood at $2.0 million, down from $3.8 million in the prior quarter.
- The five-year high for Interest Expenses was $66.4 million in Q4 2024, with the low at $8000.0 in Q4 2023.
- The 5-year median for Interest Expenses is $5.4 million (2025), against an average of $14.7 million.
- The sharpest annual moves came in 2023 and 2024: Interest Expenses sank 99.98% in 2023, then soared 829787.5% in 2024.
- Sagimet Biosciences' Interest Expenses stood at $47.8 million in 2022, then tumbled by 99.98% to $8000.0 in 2023, then jumped by 829787.5% to $66.4 million in 2024, then tumbled by 94.28% to $3.8 million in 2025, then plunged by 47.54% to $2.0 million in 2026.
- Business Quant data shows SGMT's Interest Expenses at $2.0 million in Q1 2026, $3.8 million in Q4 2025, and $7.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 439.40 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 52.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.70 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 39.74 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 335,572.77 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 218.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 82.05 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 20.27 Mn |
| 10 | Sagimet Biosciences | 649.79 Mn | 649.79 Mn | - | 13.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.93 Mn |
| Jun 30, 2026 | 13.93 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Mar 31, 2026 | 1.99 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 7.05 Mn |
| Sep 30, 2025 | 7.05 Mn |
| Jun 30, 2025 | 10.77 Mn |
| Jun 30, 2025 | 10.77 Mn |
| Mar 31, 2025 | 26,000.00 |
| Mar 31, 2025 | 26,000.00 |
| Dec 31, 2024 | 66.39 Mn |
| Dec 31, 2024 | 66.39 Mn |
| Jun 30, 2024 | 54,000.00 |
| Jun 30, 2024 | 54,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |